logo-loader
viewCEMATRIX Corp

Cematrix CEO on why it is the perfect time to be in the cellular concrete business

Cematrix Corp (TSXV:CDNX) president & CEO Jeff Kendrick speaks to Proactive about the growth of the cellular concrete market and the acquisition of U.S. competitor MixOnSite.

He discussed combined sales and EBITDA forecasts, and also highlighted the expansion of its sales and marketing partnership with Lafarge and the potential for future acquisitions.

Quick facts: CEMATRIX Corp

Price: 0.275 CAD

TSX-V:CVX
Market: TSX-V
Market Cap: $16.3 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Mereo BioPharma CEO confident as it moves forward with pivotal Setrusumab study

Mereo BioPharma's (LON:MPH) Denise Scots-Knight explains why she's confident in the potential of their lead drug setrusumab despite it not meeting its primary endpoint in a recent Phase 2b study. The drug's being developed as a treatment for osteogenesis imperfecta which is also known as...

10 minutes ago

2 min read